Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.74 (market cap $25.27B), while iShares 1 3 Year Treasury Bond ETF trades at $81.18 (market cap $26.68B). The key difference: Royalty Pharma plc Class A Ordinary Shares and iShares 1 3 Year Treasury Bond ETF are close in size by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while iShares 1 3 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| RPRX | SHY | |
|---|---|---|
Market Cap | $25.27B | $26.68B |
Volume | 3,671,183 | 4,077,691 |
Sector | Health | Fixed Income |
52-Week High | $63.96 | $83.18 |
52-Week Low | $35.44 | $81.05 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHY, a US stock, trades at $81.16, up 0.04% on the day. Technical indicators are bearish, with moving averages signaling sell pressure and oscillators neutral. The stock faces resistance and support near $81. Recent corporate actions include dividend payments, with the latest at $0.24 per share. Financial ratios are unavailable in the provided data, limiting fundamental analysis.
The outlook for SHY is cautious due to bearish technical signals and a lack of current fundamental data. Investment opportunities may arise from dividend income, but risks include market volatility and reliance on broader economic conditions. Investors should seek updated financials for a complete assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
